PORTLAND, Maine (AP) — A Maine pharmacy professor is receiving a grant of $375,000 for an early detection innovation in the breast cancer research field.
University of New England College of Pharmacy assistant professor Srinidi Mohan is receiving the grant from the Maine Cancer Foundation.
Mohan received a patent for an early detection, disease monitoring method that uses a marker in the blood to detect the presence of aggressive tumors. The university says Mohan’s innovation can also help track cancer growth.
The university says Mohan discovered the marker while studying nutritional supplements.
Most Read Stories
- Retired Alabama cop on Roy Moore: ‘We were also told to ... make sure that he didn’t hang around the cheerleaders’
- A Washington syrah was named second best wine in the world
- Expect record-high temps, 'copious rain' in Seattle area as we head toward Thanksgiving VIEW
- Fake field goal? An errant challenge? Blame Pete Carroll for Seahawks' loss to Atlanta
- Bicyclist dies in hit-and-run crash in Sodo, police say
Mohan will collaborate with Maine Medical Center Research Institute and a Maine-based company, Maine Biotechnology Services. The grant is a two-year award that will focus on developing a less-invasive indicator for certain kinds of breast tumor prognosis.